Does recurrent upper-airway collapse during sleep cause intermittent hypoxia, brief arousals, and sympathetic stress activation?

Recurrent upper-airway collapse during sleep, the hallmark of obstructive sleep apnea, initiates a dual cascade of chemical and neurophysiological stress that profoundly disrupts systemic homeostasis.

Autonomic and cardiovascular stress pathways

• Intermittent hypoxia: Airway obstruction directly causes cyclic arterial oxygen desaturation and rapid reoxygenation, manifesting as a characteristic "sawtooth" pattern. This intermittent hypoxia acts as a potent chemical stimulus that sensitizes peripheral carotid body chemoreceptors, driving elevated muscle sympathetic nerve activity (MSNA) and chronic catecholamine release.
• Sympathetic dominance: Sleep fragmentation and brief cortical micro-arousals independently trigger acute, transient spikes in sympathetic nerve activity and a reduction in vagal parasympathetic modulation. This autonomic shift leads to post-arousal heart rate and blood pressure surges.

Neuroendocrine and HPA axis activation

• Cortical arousals: Rising respiratory effort, hypoxia, and hypercapnia stimulate chemoreceptors and mechanoreceptors. This triggers brief EEG-defined micro-arousals to restore airway patency, which severely fragments sleep architecture and prevents transitions into deeper, restorative sleep stages.
• HPA axis hyperactivity: Both intermittent hypoxia and sleep fragmentation act as chronic stressors that independently activate the hypothalamic-pituitary-adrenal (HPA) axis. This dual stimulation elevates adrenocorticotropic hormone (ACTH) and 24-hour cortisol levels, leading to flattened circadian cortisol profiles.

Bottom line

• Recurrent upper-airway collapse triggers a synergistic cascade of intermittent hypoxia and sleep fragmentation. Together, these pathways activate the sympathetic nervous system and the HPA axis, driving chronic sympathetic dominance, cardiovascular stress, and endocrine dysfunction.